Collaborative care in type 2 diabetes: protecting the heart and kidneys
This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only.
Hear from colleagues in cardiology and nephrology as they discuss the opportunity in type 2 diabetes to impact cardiorenal outcomes.
AstraZeneca medicines will be mentioned during this presentation.
GB-58815, DOP: Sept 2024